Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Paradigm Shift in Tumor Immunology: Th17 Cells and TGF-β in Intestinal Cancer Initiation

Megan M. Wyatt, Chrystal M. Paulos

Cancer Res (2024)

https://doi.org/10.1158/0008-5472.CAN-24-3361

Published: 18 September 2024

View article titled, A Paradigm Shift in Tumor Immunology: Th17 Cells and TGF-β in Intestinal Cancer Initiation

Journal Articles

Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity

Guillermo O. Rangel Rivera, Connor J. Dwyer, Hannah M. Knochelmann, Aubrey S. Smith, Bülent Arman Aksoy, Anna C. Cole, Megan M. Wyatt, Soundharya Kumaresan, Jessica E. Thaxton, Gregory B. Lesinski, Chrystal M. Paulos

Cancer Res (2024) 84 (1): 69–83.

https://doi.org/10.1158/0008-5472.CAN-23-0801

Published: 02 January 2024

View article titled, Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity

Includes: Supplementary data

Journal Articles

Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer

Brian P. Riesenberg, Elizabeth G. Hunt, Megan D. Tennant, Katie E. Hurst, Alex M. Andrews, Lee R. Leddy, David M. Neskey, Elizabeth G. Hill, Guillermo O. Rangel Rivera, Chrystal M. Paulos, Peng Gao, Jessica E. Thaxton

Cancer Res (2022) 82 (23): 4386–4399.

https://doi.org/10.1158/0008-5472.CAN-22-1744

Published: 02 December 2022

View article titled, Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer

Includes: Supplementary data

Journal Articles

Abstract 5595: Statin drugs have anti-tumor activity and enhance responses to anti-PD-1 therapy in preclinical models of head and neck cancer

Andre J. Burnham, Vikash Kansal, Brendan L. Kinney, Chrystal M. Paulos, Gregory B. Lesinski, Nabil F. Saba, Nicole C. Schmitt

Cancer Res (2022) 82 (12_Supplement): 5595.

https://doi.org/10.1158/1538-7445.AM2022-5595

Published: 15 June 2022

View article titled, Abstract 5595: Statin drugs have anti-tumor activity and enhance responses to anti-PD-1 therapy in preclinical models of head and neck cancer

Journal Articles

Abstract 594: FcγRIIB expressed on activated CD8⁺ T cells restrains T cell responsiveness to αPD-1 immune checkpoint blockade in melanoma patients

Kelsey B. Bennion, Marvi Tariq, Kirsten M. Baecher, Chrystal M. Paulos, Ragini Kudchadkar, Michael C. Lowe, Mandy L. Ford

Cancer Res (2022) 82 (12_Supplement): 594.

https://doi.org/10.1158/1538-7445.AM2022-594

Published: 15 June 2022

View article titled, Abstract 594: FcγRIIB expressed on activated CD8+ T cells restrains T cell responsiveness to αPD-1 immune checkpoint blockade in melanoma patients

Journal Articles

IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors

Hannah M. Knochelmann, Connor J. Dwyer, Aubrey S. Smith, Jacob S. Bowers, Megan M. Wyatt, Michelle H. Nelson, Guillermo O. Rangel Rivera, Joshua D. Horton, Carsten Krieg, Kent Armeson, Gregory B. Lesinski, Mark P. Rubinstein, Zihai Li, Chrystal M. Paulos

Cancer Res (2020) 80 (18): 3920–3932.

https://doi.org/10.1158/0008-5472.CAN-19-3685

Published: 15 September 2020

View article titled, IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors

Includes: Supplementary data

Journal Articles

Abstract B59: IL-6 regulates CTLA4 expression on CD4+ T-cells and dual antibody blockade of IL-6 and CTLA4 leads to tumor regression in an orthotopic murine model of pancreatic ductal adenocarcinoma

Michael B. Ware, Christopher McQuinn, Thomas A. Mace, Jacob Bowers, Reena Shakya, Brad Farris, Gregory Young, William E. Carson, III, Chrystal M. Paulos, Bassel El-Rayes, Gregory B. Lesinski

Cancer Res (2019) 79 (24_Supplement): B59.

https://doi.org/10.1158/1538-7445.PANCA19-B59

Published: 13 December 2019

View article titled, Abstract B59: IL-6 regulates CTLA4 expression on CD4+ T-cells and dual antibody blockade of IL-6 and CTLA4 leads to tumor regression in an orthotopic murine model of pancreatic ductal adenocarcinoma

Journal Articles

In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo

Xiao Hu, Kinga Majchrzak, Xikui Liu, Megan M. Wyatt, Chauncey J. Spooner, Jacques Moisan, Weiping Zou, Laura L. Carter, Chrystal M. Paulos

Cancer Res (2018) 78 (14): 3888–3898.

https://doi.org/10.1158/0008-5472.CAN-17-3973

Published: 15 July 2018

View article titled, In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo

Includes: Supplementary data

Journal Articles

Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8⁺ T Cells

C. Bryce Johnson, Bennett R. May, Brian P. Riesenberg, Samantha Suriano, Shikhar Mehrotra, Elizabeth Garrett-Mayer, Mohamed L. Salem, Emily K. Jeng, Hing C. Wong, Chrystal M. Paulos, John M. Wrangle, David J. Cole, Mark P. Rubinstein

Cancer Res (2018) 78 (11): 3067–3074.

https://doi.org/10.1158/0008-5472.CAN-17-2153

Published: 31 May 2018

View article titled, Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells

Includes: Supplementary data

Journal Articles

Lack of p53 Augments Antitumor Functions in Cytolytic T Cells

Cancer Res (2016) 76 (18): 5229–5240.

https://doi.org/10.1158/0008-5472.CAN-15-1798

Published: 15 September 2016

View article titled, Lack of p53 Augments Antitumor Functions in Cytolytic T Cells

Includes: Supplementary data

Journal Articles

Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors

Shilpak Chatterjee, Krishnamurthy Thyagarajan, Pravin Kesarwani, Jin H. Song, Myroslawa Soloshchenko, Jianing Fu, Stefanie R. Bailey, Chenthamarkshan Vasu, Andrew S. Kraft, Chrystal M. Paulos, Xue-Zhong Yu, Shikhar Mehrotra

Cancer Res (2014) 74 (21): 6048–6059.

https://doi.org/10.1158/0008-5472.CAN-14-1450

Published: 30 October 2014

View article titled, Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors

Includes: Supplementary data

Journal Articles

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

Yangbing Zhao, Edmund Moon, Carmine Carpenito, Chrystal M. Paulos, Xiaojun Liu, Andrea L. Brennan, Anne Chew, Richard G. Carroll, John Scholler, Bruce L. Levine, Steven M. Albelda, Carl H. June

Cancer Res (2010) 70 (22): 9053–9061.

https://doi.org/10.1158/0008-5472.CAN-10-2880

Published: 14 November 2010

View article titled, Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

Includes: Supplementary data

NARROW

A Paradigm Shift in Tumor Immunology: Th17 Cells and TGF-β in Intestinal Cancer Initiation

Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity

Stress-Mediated Attenuation of Translation Undermines T-cell Activity in Cancer

Abstract 5595: Statin drugs have anti-tumor activity and enhance responses to anti-PD-1 therapy in preclinical models of head and neck cancer

Abstract 594: FcγRIIB expressed on activated CD8⁺ T cells restrains T cell responsiveness to αPD-1 immune checkpoint blockade in melanoma patients

IL6 Fuels Durable Memory for Th17 Cell–Mediated Responses to Tumors

Abstract B59: IL-6 regulates CTLA4 expression on CD4+ T-cells and dual antibody blockade of IL-6 and CTLA4 leads to tumor regression in an orthotopic murine model of pancreatic ductal adenocarcinoma

In Vitro Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness In Vivo

Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8⁺ T Cells

Lack of p53 Augments Antitumor Functions in Cytolytic T Cells

Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors

Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only